Delivery Order SPE2DB20D3101-SPE2DB25FRQB6
- Not listed
- The Defense Logistics Agency awarded a $19,199.10 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with a completion date of June 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $14,056.91 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of May 6, 2025. This contract represents a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $38,088.74 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of June 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $10,179.03 to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick autoinjectors, with an ultimate completion date of September 15, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $77,016.20 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,207.79 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors. The contract, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $41,137.81 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of August 27, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical supply to be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $34,017.92 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed-price contract on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting military healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and fulfill this...
- The Defense Logistics Agency awarded a $25,796.39 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of August 20, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial pharmaceutical supply relationship with DLA, supporting federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $128,358.41 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-competitive award leveraging an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRQB6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,507.12 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of July 15, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical products to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply chain, delivering an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative is expected to make multiple regional awards, positioning AmerisourceBergen among the key strategic vendors supporting federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 7/14/25 |